Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup

NCT ID: NCT00717912

Last Updated: 2017-07-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine the glycemic index and the insulinemic index of a sweetener syrup

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Glycemic index is a measure of how carbohydrate-containing foods affect blood glucose levels. All foods that contain carbohydrates, such as starchy vegetables (potatoes, corn), desserts, fruits, bread, pasta, and rice, can be tested for how they affect blood sugar levels after being eaten. Glycemic index is assessed by having one or more people eat a specific amount of a single food (usually 50 grams of digestible carbohydrate) and then measuring the change in blood sugar levels compared with the levels achieved after they have eaten a control food containing the same amount of digestible carbohydrate, such as white bread or glucose. The average change in blood sugar levels over a set period of time relative to the levels after consumption of the control food, usually white bread or glucose, is the food's glycemic index.

Insulinemic index is measure with the same methodology.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup

Group Type EXPERIMENTAL

Experimental sweetener syrup

Intervention Type OTHER

3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sweetener syrup

Intervention Type OTHER

1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sugar syrup

Intervention Type OTHER

3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber

Arm 2

Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Experimental sweetener syrup

Group Type EXPERIMENTAL

Experimental sweetener syrup

Intervention Type OTHER

3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sweetener syrup

Intervention Type OTHER

1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sugar syrup

Intervention Type OTHER

3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber

Arm 3

Experimental sweetener syrup / Classical sugar syrup / Experimental sweetener syrup / Classical sweetener syrup / Classical sugar syrup / Classical sugar syrup / Experimental sweetener syrup

Group Type EXPERIMENTAL

Experimental sweetener syrup

Intervention Type OTHER

3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sweetener syrup

Intervention Type OTHER

1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sugar syrup

Intervention Type OTHER

3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber

Arm 4

Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup / Classical sugar syrup / Classical sweetener syrup

Group Type EXPERIMENTAL

Experimental sweetener syrup

Intervention Type OTHER

3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sweetener syrup

Intervention Type OTHER

1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sugar syrup

Intervention Type OTHER

3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber

Arm 5

Classical sugar syrup / Experimental sweetener syrup / Classical sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sugar syrup

Group Type EXPERIMENTAL

Experimental sweetener syrup

Intervention Type OTHER

3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sweetener syrup

Intervention Type OTHER

1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sugar syrup

Intervention Type OTHER

3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber

Arm 6

Experimental sweetener syrup / Experimental sweetener syrup / Experimental sweetener syrup / Classical sugar syrup / Classical sweetener syrup / Classical sugar syrup / Classical sugar syrup

Group Type EXPERIMENTAL

Experimental sweetener syrup

Intervention Type OTHER

3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sweetener syrup

Intervention Type OTHER

1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Classical sugar syrup

Intervention Type OTHER

3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental sweetener syrup

3 glucose and insulin responses with experimental sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Intervention Type OTHER

Classical sweetener syrup

1 glucose and insulin responses with classical sweetener syrup : 50 grams of digestible carbohydrate plus fiber

Intervention Type OTHER

Classical sugar syrup

3 glucose and insulin responses with classical sugar syrup : 50 grams of digestible carbohydrate plus fiber

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-50 years
* male
* healthy volunteers
* BMI above 25 kg/m²

Exclusion Criteria

* no medical history of hypercholesterolemia, high pressure blood, diabetes, sugar intolerance
* food allergy
* kidney deficiency
* liver troubles
* gastro-intestinal troubles
* drugs which impair sugar and lipid metabolism
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Routin SA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Marc Cazaubiel, Doctor

Role: PRINCIPAL_INVESTIGATOR

BioFortis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Biofortis

Nantes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Related Links

Access external resources that provide additional context or updates about the study.

http://www.biofortis.eu/

Clinical Research Organisation in Human Nutrition

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SIRODEX 9708

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.